Abcg2 overexpression represents a novel mechanism for acquired resistance to the multi-kinase inhibitor Danusertib in BCR-ABL-positive cells in vitro. [PDF]
The success of Imatinib (IM) therapy in chronic myeloid leukemia (CML) is compromised by the development of IM resistance and by a limited IM effect on hematopoietic stem cells.
Carsten Bokemeyer +40 more
core +2 more sources
Neutrophils: Heterogeneity, Biology, Diseases, and Therapeutic Strategies
Neutrophils exhibit remarkable functional plasticity and play dual roles in tissue protection and disease progression. This review summarizes their key biological functions and highlights the shift from conventional broad‐spectrum interventions to neutrophil‐based drug delivery systems.
Yibing Zhang +4 more
wiley +1 more source
Ubiquitination and Deubiquitination: From Molecular Mechanisms to Therapeutic Strategies
Ubiquitination and deubiquitination form a reversible regulatory network that controls protein stability, localization, interactions, chromatin association, and signaling. E3 ligases generate distinct ubiquitin signals; DUBs remove or remodel them; and ubiquitin‐binding proteins decode chain topology and cellular context.
Wanqing Liu +5 more
wiley +1 more source
This review provides an update on the epidemiology, pathogenesis, and clinical/histologic features of cutaneous leiomyosarcoma. Prognostic factors (e.g., depth of tumor involvement, grade, etc.) that can facilitate risk stratification are also discussed, as are treatment approaches for this rare malignancy.
Tejas P. Joshi +4 more
wiley +1 more source
Atypical chronic myeloid leukemia with der(20)t(17;20)(q21;q13)
We present a case of atypical chronic myeloid leukemia that developed blastic transformation four months after initial presentation, with the blast cells showing multilineage antigen expression.
Ma, SK +9 more
core +1 more source
Chronic myeloid leukemia with involvement of membranous labyrinth
This case report explains an extraordinary presentation of chronic myeloid leukemia (CML) in a 39-year-old male with a T315I mutation, presenting with acute bilateral hearing loss and imbalance secondary to myeloid blast crisis.
Mobachir El Kettani +4 more
doaj +1 more source
Natural Product‐Induced Ferroptosis to Overcome Therapy Resistance in Aggressive Cancers
Natural products trigger ferroptosis through iron overload, glutathione depletion, glutathione peroxidase 4 inhibition, and reactive oxygen species accumulation, selectively targeting aggressive, and drug‐resistant cancers. Polyphenols, alkaloids and terpenoids emerge as promising multi‐target agents to overcome therapy resistance and improve future ...
Giorgio Antoniolli
wiley +1 more source
Avapritinib treatment of KIT D816V-mutant atypical chronic myeloid leukemia. [PDF]
Sandow L, Heinrich M.
europepmc +1 more source
Not So Typical: Development of Atypical Chronic Myeloid Leukemia in a Patient With Chronic Myeloid Leukemia [PDF]
Raya, Saba +2 more
openaire +2 more sources
A Case of Atypical Chronic Myeloid Leukemia with the JAK2V617F Mutation
김주연·이세련·남명현·윤수영·임채승·이창규·김병수·조윤정·김영기·이갑노 Ju Yeon Kim, M.D., Se Ryeon Lee, M.D., Myung-Hyun Nam, M.D., Soo-Young Yoon, M.D., Chae Seung Lim, M.D., Chang Kyu Lee, M.D., Byung Soo Kim, M.D., Yunjung Cho, M.D., Young Kee Kim, M.D., Kap No Lee, M.D. 고려대학교 의과대학 진단검사의학교실, 내과학교실 Departments of Laboratory Medicine and Internal Medicine, Korea University College ...
Ju Yeon Kim +9 more
openaire +1 more source

